Glioblastoma and other primary brain malignancies in adults: a review

LR Schaff, IK Mellinghoff - Jama, 2023 - jamanetwork.com
Importance Malignant primary brain tumors cause more than 15 000 deaths per year in the
United States. The annual incidence of primary malignant brain tumors is approximately 7 …

Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019

RF Duarte, M Labopin, P Bader, GW Basak… - Bone marrow …, 2019 - nature.com
This is the seventh special EBMT report on the indications for haematopoietic stem cell
transplantation for haematological diseases, solid tumours and immune disorders. Our aim …

Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022

JA Snowden, I Sánchez-Ortega… - Bone marrow …, 2022 - nature.com
For over two decades, the EBMT has updated recommendations on indications for
haematopoietic cell transplantation (HCT) practice based on clinical and scientific …

Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 …

AJM Ferreri, K Cwynarski, E Pulczynski, CP Fox… - Leukemia, 2022 - nature.com
Abstract 219 HIV-negative adults≤ 70 years with primary CNS lymphoma (PCNSL) were
enrolled in the randomized IELSG32 trial. Enrolled patients were randomly assigned to …

Post‐transplant lymphoproliferative disorders, Epstein‐Barr virus infection, and disease in solid organ transplantation: Guidelines from the American Society of …

UD Allen, JK Preiksaitis… - Clinical …, 2019 - Wiley Online Library
These updated guidelines from the American Society of Transplantation Infectious Diseases
Community of Practice review the diagnosis, management, and prevention of post …

[HTML][HTML] Indications for hematopoietic cell transplantation and immune effector cell therapy: guidelines from the American Society for Transplantation and Cellular …

AS Kanate, NS Majhail, BN Savani, C Bredeson… - Biology of Blood and …, 2020 - Elsevier
Abstract The American Society for Transplantation and Cellular Therapy (ASTCT) published
its first white paper on indications for autologous and allogeneic hematopoietic cell …

Radiotherapy or autologous stem-cell transplantation for primary CNS lymphoma in patients 60 years of age and younger: results of the intergroup ANOCEF …

C Houillier, L Taillandier, S Dureau, T Lamy… - Journal of clinical …, 2019 - ascopubs.org
PURPOSE To determine the efficacy and toxicity of chemoimmunotherapy followed by either
whole-brain radiotherapy (WBRT) or intensive chemotherapy and autologous stem-cell …

European Association of Neuro-Oncology (EANO) guidelines for treatment of primary central nervous system lymphoma (PCNSL)

K Hoang-Xuan, M Deckert, AJM Ferreri… - Neuro …, 2023 - academic.oup.com
The management of primary central nervous system (PCNSL) is one of the most
controversial topics in neuro-oncology because of the complexity of the disease and the …

Management and outcome of primary CNS lymphoma in the modern era: an LOC network study

C Houillier, C Soussain, H Ghesquières, P Soubeyran… - Neurology, 2020 - AAN Enterprises
Objective Real-life studies on patients with primary CNS lymphoma (PCNSL) are scarce.
Our objective was to analyze, in a nationwide population-based study, the current medical …

Comprehensive approach to diagnosis and treatment of newly diagnosed primary CNS lymphoma

C Grommes, JL Rubenstein, LM DeAngelis… - Neuro …, 2019 - academic.oup.com
Primary central nervous system lymphoma (PCNSL) is a rare form of non-Hodgkin
lymphoma that affects the brain parenchyma, spinal cord, eyes, and cerebrospinal fluid …